rrDLBCL
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study of Pembrolizumab (MK-3475) in Combination With Dinaciclib (MK-7965) in Hematologic Malignancies (MK-3475-155/KEYNOTE-155) (NCT02684617) | Merck Sharp & Dohme LLC | 2016-03-29 |
Track rrDLBCL automatically
Every clearance here is in the API, with alerts when new ones post.